featured
Evaluation of Oral Corticosteroid–Sparing Effect of Tezepelumab in Adults With Oral Corticosteroid–Dependent Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
Lancet Respir Med 2022 Mar 29;[EPub Ahead of Print], ME Wechsler, A Menzies-Gow, CE Brightling, P Kuna, S Korn, T Welte, JM Griffiths, K Sałapa, Å Hellqvist, G Almqvist, H Lal, P Kaur, T Skärby, G ColiceFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.